Weekly Top Insider Sells: TJX, MON, REGN, and PNC

Author's Avatar
Jan 16, 2012
According to GuruFocus Insider Data, these are the largest insider sells during the past week.


TJX Cos. (TJX, Financial): Senior Vice President, CFO Jeffrey G. Naylor sold 92,567 Shares


Senior Vice President and CFO of TJX Cos. (TJX) Jeffrey G. Naylor sold 92,567 shares during the past week at an average price of $65.15.


The TJX Companies Inc. is the off-price retailer of apparel and home fashions in the U.S. TJX Cos. has a market cap of $24.57 billion; its shares were traded at around $65.15 with a P/E ratio of 17.2 and P/S ratio of 1.1. The dividend yield of TJX Cos. stocks is 1.2%. TJX Cos. had an annual average earnings growth of 13.5% over the past 10 years. GuruFocus rated TJX Cos. the business predictability rank of 4-star.


On November 15 The TJX Companies Inc. announced sales and earnings results for the third quarter ended Oct. 29, 2011. Net sales for the third quarter of Fiscal 2012 increased 5% to $5.8 billion and consolidated comparable store sales increased 3%. Net income for the third quarter was $406 million and diluted earnings per share were $1.06, up 15% over $.92 per share last year.


Director Willow B. Shire sold 500 shares of TJX stock on 11/22/2011 at the average price of $59.15. Willow B. Shire owns at least 7,247 shares after this. The price of the stock has increased by 10.14% since.


Monsanto Co. (MON, Financial): Executive Vice President and Chief Technology Officer Robert T. Fraley sold 70,110 Shares


Executive Vice President and Chief Technology Officer of Monsanto Co. (MON) Robert T. Fraley sold 70,110 shares on 01/10/2012 at an average price of $79.59.


Monsanto is a global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. Monsanto Co. has a market cap of $42.61 billion; its shares were traded at around $79.59 with a P/E ratio of 25.3 and P/S ratio of 3.6. The dividend yield of Monsanto Co. stocks is 1.5%. Monsanto Co. had an annual average earnings growth of 22.5% over the past 10 years. GuruFocus rated Monsanto Co. the business predictability rank of 4.5-star.


On October 15 Monsanto reported net sales of $2.2 billion for the fourth quarter of fiscal year 2011. Net sales for the fiscal year were $11.8 billion. Seeds and Genomics net sales were $1.4 billion for the quarter, a 39 percent increase over the prior year. For the fourth quarter, the company reported a loss per share of $(0.22) on an ongoing basis and $(0.21) on an as-reported basis. As-reported EPS results for the fourth quarter and fiscal year 2011 reflect the effects of restructuring and discontinued operations. (For a reconciliation of ongoing EPS, see page 1 and note 1.)


Executive Vice President and Chief Commercial Officer Brett D. Begemann sold 35,437 shares of MON stock on 07/25/2011 at the average price of $76. Brett D. Begemann owns at least 116,819 shares after this. The price of the stock has increased by 4.72% since.


Regeneron Pharmaceuticals Inc. (REGN, Financial): VP Regulatory Development and William Roberts sold 31,676 Shares


VP Regulatory Development and of Regeneron Pharmaceuticals Inc. (REGN) William Roberts sold 31,676 shares on 01/11/2012 at an average price of $78.92. Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron Pharmaceuticals Inc. has a market cap of $7.31 billion; its shares were traded at around $78.92 with and P/S ratio of 15.9.


On Oct. 27, 2011 Regeneron Pharmaceuticals Inc. announced financial results for the third quarter of 2011 and provided an update on development programs and upcoming milestones. The Company's total revenues decreased to $102.8 million in the third quarter of 2011 from $106.0 million in the same quarter of 2010, primarily due to lower technology licensing revenue as the Company's VelocImmune® license agreement with AstraZeneca ended in February 2011.


Senior Vice President Finance and Admin CFO Trea Murray A. Goldberg sold 4,200 shares of REGN stock on 09/21/2011 at the average price of $67. Murray A. Goldberg owns at least 83,150 shares after this. The price of the stock has increased by 17.79% since.


PNC Financial Services Group Inc. (PNC, Financial): Executive Vice President and Chief HR Officer Joan L. Gulley sold 42,750 Shares


Executive Vice President and Chief HR Officer of PNC Financial Services Group Inc. (PNC) Joan L. Gulley sold 42,750 shares on 01/12/2012 at an average price of $61.73. The PNC Financial Services Group Inc. is one of the nation's largest diversified financial services organizations, providing regional banking, corporate banking, real estate finance, asset-based lending, wealth management, asset management and global fund services. PNC Financial Services Group Inc. has a market cap of $32.48 billion; its shares were traded at around $61.73 with a P/E ratio of 9.7 and P/S ratio of 1.9. The dividend yield of PNC Financial Services Group Inc. stocks is 2.3%. PNC Financial Services Group Inc. had an annual average earnings growth of 5.9% over the past 10 years.


On Oct. 19, 2011 the PNC Financial Services Group, Inc. reported third quarter net income of $834 million, or $1.55 per diluted common share. Net income for the second quarter of 2011 was $912 million, or $1.67 per diluted common share, and $1.1 billion, or $2.07 per diluted common share, for the third quarter of 2010. Third quarter 2010 included an after tax gain of $328 million, or $.62 per diluted common share, for the sale of PNC Global Investment Servicing.


Chairman and CEO James E. Rohr sold 273,000 shares of PNC stock on 01/03/2012 at the average price of 59.25. James E. Rohr owns at least 610,414 shares after this. The price of the stock has increased by 4.19% since.


For the complete list of stocks that bought/sold by their company executives, go to: Insider Buys.